Dien M Tran1, Mattias Larsson2, Linus Olson2, Ngoc T B Hoang1, Ngai K Le3, Dung T K Khu3, Hung D Nguyen4, Tam V Vu5, Tinh H Trinh6, Thinh Q Le7, Phuong T T Phan8, Binh G Nguyen9, Nhung H Pham9, Bang H Mai10, Tuan V Nguyen10, Phuong T K Nguyen10, Nhan D Le11, Tuan M Huynh12, Le T Anh Thu13, Tran C Thanh14, Björn Berglund15, Lennart E Nilsson15, Elin Bornefall15, Le H Song10, Håkan Hanberger16. 1. Vietnam National Children's Hospital, Hanoi, Vietnam. 2. Training and Research Academic Collaboration Sweden-Vietnam, Vietnam; Department of Public Health Sciences, Karolinska Institutet, Sweden. 3. Vietnam National Children's Hospital, Hanoi, Vietnam; Training and Research Academic Collaboration Sweden-Vietnam, Vietnam. 4. St Paul Hospital, Hanoi, Vietnam. 5. Uong Bi Hospital, Quang Ninh, Vietnam. 6. Binh Dinh General Hospital, Vietnam. 7. Children's Hospital 1, Ho Chi Minh City (HCMC), Vietnam. 8. Phu San Hanoi, Vietnam. 9. Bach Mai Hospital, Hanoi, Vietnam. 10. 108 Military Central Hospital, Hanoi, Vietnam. 11. Da Nang General Hospital, Vietnam. 12. University Medical Clinic, HCMC, Vietnam. 13. Cho Ray Hospital, HCMC, Vietnam. 14. Training and Research Academic Collaboration Sweden-Vietnam, Vietnam. 15. Department of Clinical and Experimental Medicine, Faculty of Medicine and Health Sciences, Linköping University, Sweden. 16. Training and Research Academic Collaboration Sweden-Vietnam, Vietnam; Department of Clinical and Experimental Medicine, Faculty of Medicine and Health Sciences, Linköping University, Sweden. Electronic address: hakan.hanberger@liu.se.
Abstract
BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) is an increasing problem worldwide, but particularly problematic in low- and middle-income countries (LMIC) due to limitations of resources for surveillance of CRE and infection prevention and control (IPC). METHODS: A point prevalence survey (PPS) with screening for colonisation with CRE was conducted on 2233 patients admitted to neonatal, paediatric and adult care at 12 Vietnamese hospitals located in northern, central and southern Vietnam during 2017 and 2018. CRE colonisation was determined by culturing of faecal specimens on selective agar for CRE. Risk factors for CRE colonisation were evaluated. A CRE admission and discharge screening sub-study was conducted among one of the most vulnerable patient groups; infants treated at an 80-bed Neonatal ICU from March throughout June 2017 to assess CRE acquisition, hospital-acquired infection (HAI) and treatment outcome. RESULTS: A total of 1165 (52%) patients were colonised with CRE, most commonly Klebsiella pneumoniae (n = 805), Escherichia coli (n = 682) and Enterobacter spp. (n = 61). Duration of hospital stay, HAI and treatment with a carbapenem were independent risk factors for CRE colonisation. The PPS showed that the prevalence of CRE colonisation increased on average 4.2% per day and mean CRE colonisation rates increased from 13% on the day of admission to 89% at day 15 of hospital stay. At the NICU, CRE colonisation increased from 32% at admission to 87% at discharge, mortality was significantly associated (OR 5·5, P < 0·01) with CRE colonisation and HAI on admission. CONCLUSION: These data indicate that there is an epidemic spread of CRE in Vietnamese hospitals with rapid transmission to hospitalised patients.
BACKGROUND:Carbapenem-resistant Enterobacteriaceae (CRE) is an increasing problem worldwide, but particularly problematic in low- and middle-income countries (LMIC) due to limitations of resources for surveillance of CRE and infection prevention and control (IPC). METHODS: A point prevalence survey (PPS) with screening for colonisation with CRE was conducted on 2233 patients admitted to neonatal, paediatric and adult care at 12 Vietnamese hospitals located in northern, central and southern Vietnam during 2017 and 2018. CRE colonisation was determined by culturing of faecal specimens on selective agar for CRE. Risk factors for CRE colonisation were evaluated. A CRE admission and discharge screening sub-study was conducted among one of the most vulnerable patient groups; infants treated at an 80-bed Neonatal ICU from March throughout June 2017 to assess CRE acquisition, hospital-acquired infection (HAI) and treatment outcome. RESULTS: A total of 1165 (52%) patients were colonised with CRE, most commonly Klebsiella pneumoniae (n = 805), Escherichia coli (n = 682) and Enterobacter spp. (n = 61). Duration of hospital stay, HAI and treatment with a carbapenem were independent risk factors for CRE colonisation. The PPS showed that the prevalence of CRE colonisation increased on average 4.2% per day and mean CRE colonisation rates increased from 13% on the day of admission to 89% at day 15 of hospital stay. At the NICU, CRE colonisation increased from 32% at admission to 87% at discharge, mortality was significantly associated (OR 5·5, P < 0·01) with CRE colonisation and HAI on admission. CONCLUSION: These data indicate that there is an epidemic spread of CRE in Vietnamese hospitals with rapid transmission to hospitalised patients.
Authors: Nicoleta-Dorina Vlad; Roxana Carmen Cernat; Sorina Carp; Romelia Mitan; Andrei Dumitru; Codruța Nemet; Septimiu Voidăzan; Sorin Rugină; Irina-Magdalena Dumitru Journal: J Int Med Res Date: 2022-10 Impact factor: 1.573
Authors: Alexandra Vasilakopoulou; Polyxeni Karakosta; Sophia Vourli; Aikaterini Tarpatzi; Paraskevi Varda; Maria Kostoula; Anastasia Antoniadou; Spyros Pournaras Journal: Front Public Health Date: 2020-03-18
Authors: Chris R Taitt; Tomasz A Leski; Michael G Prouty; Gavin W Ford; Vireak Heang; Brent L House; Samuel Y Levin; Jennifer A Curry; Adel Mansour; Hanan El Mohammady; Momtaz Wasfy; Drake Hamilton Tilley; Michael J Gregory; Matthew R Kasper; James Regeimbal; Paul Rios; Guillermo Pimentel; Brook A Danboise; Christine E Hulseberg; Elizabeth A Odundo; Abigael N Ombogo; Erick K Cheruiyot; Cliff O Philip; Gary J Vora Journal: Int J Mol Sci Date: 2020-08-18 Impact factor: 5.923
Authors: Thanh C Tran; Binh T Pham; Van H Pham; The A Ngo; Håkan Hanberger; Mattias Larsson; Linus Olson Journal: Microbiologyopen Date: 2020-11-09 Impact factor: 3.139
Authors: Nguyen Thanh Viet; Vu Van Du; Nghiem Duc Thuan; Hoang Van Tong; Nguyen Linh Toan; Can Van Mao; Nguyen Van Tuan; Srinivas Reddy Pallerla; Dennis Nurjadi; Thirumalaisamy P Velavan; Ho Anh Son Journal: Antibiotics (Basel) Date: 2021-05-13
Authors: Jin Ju Park; Yu Bin Seo; Jacob Lee; Joong Sik Eom; Wonkeun Song; Young Kyun Choi; Sung Ran Kim; Hee Jung Son; Nan Hyoung Cho Journal: J Korean Med Sci Date: 2020-09-14 Impact factor: 2.153
Authors: Thi Lan Huong Vu; Quoc Dat Vu; Bao Long Hoang; Thi Cam Tu Nguyen; Thi Dieu Ngan Ta; Behzad Nadjm; H Rogier van Doorn Journal: JAC Antimicrob Resist Date: 2020-11-10